Zenotech Lab. (532039)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At ₹64.90, Zenotech Lab commands a market cap of ₹402 crore. Last quarter sales were ₹13 crore and net profit ₹2 crore, which annualises to roughly ₹8 crore of earnings. Yet the trailing P/E sits at 75.24. That is a rich price for any business, especially one with ROE of just 3.55%. As Graham would say, price is what you pay, value is what you get. I am getting only ₹3.55 of earnings power for every ₹100 of book value, and I am being asked to pay 4.14 times book. There is no dividend yield, so my return depends entirely on the market reappraising this stock. The 59.26% profit growth sounds exciting, but sales growth is only 14.41%. That gap can come from margin expansion, but with a lowly ROCE of 9.40%, I am not convinced the business has a durable moat. The Piotroski F-Score of 7/9 is a small positive, and the company may be financially sound, but a sound business at too high a price is still a poor investment. The PEG ratio of 2.04 tells me I am paying more than twice the growth rate when adjusted for earnings yield, which is not a bargain. This looks like a fast grower that the market has already discovered; the stock is at its 52-week high. I need to see much better capital efficiency and a wider margin of safety before I would consider putting my money here. For now, I would rather be patient and miss the trade than overpay for hope.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer